| Abstract|| |
Background: Escherichia coli is well known as noninvasive commensal and has been established as etiological agent of various human infections. E. coli also contributes to high rate of resistance to several antibiotics due to multiresistant antibiotic plasmid genes e.g., extended spectrum β-lactamases (ESBL). Material and Methods: To analyse the situation of antibiotic resistance, a total of 77 E.coli isolates from urine, pus, sputum and endotracheal aspirate were screened for their antibiograms for antibiotic resistance, multiple antibiotic resistance (MAR) index for evaluating the spread of resistance and plasmid profiles for the presence and characterization of plasmids. Results: Very high resistance level (> 90%) was detected against ampicillin, amoxycillin, ceftazidime, norfloxacin, tetracycline while imipenem and amikacin recorded the least resistance levels of 2.3% and 13.9%, respectively, among the isolates. An increased resistance to amoxycillin, tetracycline, cotrimoxazole and norfloxacin were observed in this geographical area which however displayed a lower resistance in other countries. The MAR index varied considerably, the lowest was 0.18 and the highest was 0.89. Plasmids of 10 size ranges were detected in the isolates. Some isolates possessed single-sized plasmid while other possessed multiple plasmids. Isolates with high MAR profiles were found to possess multiple plasmids. Conclusion: Regular antimicrobial sensitivity surveillance is necessary and acquisition of plasmid could greatly contribute in the antibiotic resistance and poses a significant risk of the spread of microbial resistance in this community. Also, it was observed that route of administration of antibiotics perhaps reduced its misuse and hence led to the reduction in the emergence of resistant bacterial strains.
Keywords: Antibiogram, E. coli, extended spectrum β-lactamases, multiple antibiotic resistance index, plasmid profile
|How to cite this article:|
Christopher AF, Hora S, Ali Z. Investigation of plasmid profile, antibiotic susceptibility pattern multiple antibiotic resistance index calculation of Escherichia coli isolates obtained from different human clinical specimens at tertiary care hospital in Bareilly-India. Ann Trop Med Public Health 2013;6:285-9
|How to cite this URL:|
Christopher AF, Hora S, Ali Z. Investigation of plasmid profile, antibiotic susceptibility pattern multiple antibiotic resistance index calculation of Escherichia coli isolates obtained from different human clinical specimens at tertiary care hospital in Bareilly-India. Ann Trop Med Public Health [serial online] 2013 [cited 2020 Aug 8];6:285-9. Available from: http://www.atmph.org/text.asp?2013/6/3/285/120985
| Introduction|| |
Escherichia More Details coli are a multitalented, very adaptive, enteric Gram-negative bacillus, which belongs to the family Enterobacteriaeceae. Most strains of E. coli live as commensal, many perhaps all are opportunistic pathogens of humans. E. coli is one of the main causes of both nosocomial and community acquired infections in humans. The organism is therefore of clinical importance and can be isolated from various clinical specimens. It is one of the organisms most frequently isolated from blood. ,, E. coli has now been established as etiological agents of human gastroenteritis, enteric fever, septicemia, localized infections and diarrhea disease of humans. 
The antibiotic susceptibility of bacterial isolates is not constant but dynamic and varies with time and environment.  Indeed, high resistance rate to several antimicrobial agents have been observed in commensal bacteria in developing countries.  E. coli is highly resistant to ampicillin, amoxycillin, tetracycline and trimethoprim - sulfamethoxazole.  E. coli, became resistant as a result of genetic mutations or acquisition of pre-existing genes that confer resistance which occur either in the deoxyribonucleic acid (DNA) of the bacteria chromosomes or plasmids. , Thus antibiotic resistance can be disseminated to other bacteria by the plasmid during conjugation.  The rapid spread of antibiotics resistance genes in bacterial population is due to selective pressure resulting from the intensive and the indiscriminate use of antibiotics in human therapy.  This rapid dissemination of drug-resistant bacteria is an increasing global concern, as it seriously complicates the treatment of infections. , The association of these pathogenic organisms with diseases in humans has increased the importance of epidemiological studies. This demands the need for periodic screening of common bacterial pathogens for their antibiotic susceptibility profiles in different communities. Therefore, E. coli could serve as an indicator bacterium for so called 'alert organism surveillance'.  Historically, serotyping has been extensively used for identification of Salmonella More Details, Pseudomonas and E. coli for epidemiological purposes but several other methods, including phage typing, biotyping, antibiotic resistance determination and plasmid profile analysis are now available. A number of plasmid screening procedures which vary in subtle ways have been used for the detection of plasmid.  In this study, we investigated the resistance profile of E. coli isolates obtained from urine, pus, sputum and endotracheal aspirate to common antibiotics and the existence of plasmid DNA which confer antibiotic resistance in E. coli.
| Materials and Methods|| |
A total of 77 clinical specimens comprising urine, pus, sputum and endotracheal aspirate of patients attending Shri Ram Murti Smarak Institute of Medical Sciences (SRMS-IMS), Bareilly, India positive for E. coli was screened for antibiograms and plasmid profile. The specimens were processed at SRMS-IMS Hospital, using standard microbiological methods.  Plasmid profile was carried out at the Central Research Laboratory, SRMS-IMS, Bareilly.
Antibiotic susceptibility testing
Susceptibility of isolates to antibiotics were tested using the disk diffusion method on Mueller Hinton agar by Bauer-Kirby Method (Hi-media, Mumbai) against the following antibiotics, namely Ampicillin (10 μg), Ceftriaxone/Cefotaxime (30/30 μg), Ceftazidime (30μg), Tobramycin (10 μg), Nitrofurantoin (300 μg), Co-trimoxazole (1.25/23.75 μg), Norfloxacin (30μg), Tetracycline (30μg), Gentamycin (10μg), Amikacin (30μg), Ciprofloxacin (5μg), Piperacillin/Tazobactum (100/10μg), Cefoparazone+Sulbactam (75/10 μg), Imipenem (10μg), Amoxycillin+Clavulanic acid (20/10 μg),. The sensitivity tests were standardized using E. coli ATCC no. 25922). Discs were consistently tested for efficacy against standard strains recommended by Clinical Laboratory Standards Institute.  Inhibition zones sizes were interpreted in accordance to Performance Standards for Antimicrobial Disk Susceptibility Tests, CLSI. Results were interpreted as percent sensitive (% S) and percent resistant (% R) isolates derived using CLSI and WHO breakpoints. Intermediate isolates were counted as resistant to all the agents tested. A multiple drug resistance (MDR) phenotype was defined as resistance to≥2 antimicrobial agents. Only E. coli isolates which showed MDR (58 isolates) were included for further investigation for multiple antibiotic resistance(MAR) index study and plasmid profile analysis.
MAR index is a tool to analyze health risk and is helpful to check the spread of bacterial resistance in a given population where there is resistance to more than three antibiotics.  It is calculated as the number of antibiotics to which test isolate displayed resistance divided by total number of antibiotics to which the test organism has been evaluated for sensitivity. The value of MAR index 0.2 differentiate the low and high risk. MAR index greater than 0.2 implies that the strain of such bacteria originate from an environment where several antibiotics are used.
Isolation and separation of plasmid DNA
Plasmids DNA isolation was done using small-scale alkaline lysis method as described by Sambrook et al. Agarose gel electrophoresis was performed on 0.8% (w/v) agarose and stained with ethidum bromide (0.5 μg/ml). Plasmid profiles were documented under UV light in Gel Documentation System (UVP., USA).
Determination of molecular weight of plasmid
Molecular weight of plasmids from E.coli isolates was determined by comparing with molecular weight DNA maker (Lambda DNA/Hind III digest and 1 kb DNA ladder). Images of gels were captured on DigiDoc-It TM Imaging System and molecular weight of test plasmids were determined by comparing them with the DNA marker using the Doc-It ® LS image analysis software. For reproducibility testing, comparison of plasmid with DNA marker was done thrice and an average of two readings obtained for each isolate was affirmed as the final molecular weight of the test plasmid.
| Results|| |
A total of 58 E. coli isolates were selected and analyzed for resistance ability against different antibiotics. E.coli isolates displayed 100% resistance toward ampicillin, 93.3% isolates were resistant to ceftazidime, 91.3% were resistant to amoxycillin/clavulanic acid, 89.4% isolates were resistant to ciprofloxacin, 78.5% isolates were resistant to cotrimaxazole, 24% isolates were resistant to nitrofurantoin, 14% isolates were resistant to amikacin and 2.32% isolates were resistant to imipenem. The results of antibiotic resistance pattern are summarized in [Table 1].
|Table 1: Antibiotic sensitivity profiles of E. coli isolated from 58 clinical samples|
Click here to view
Among the antibiotics, imipenem was most effective with 100% sensitivity in the E. coli isolates from urine sample followed by amikacin with 14.8% resistance. In E. coli isolates from sputum samples, amikacin and imipenem both were equally effective with 4.5% resistance. In E.coli isolates from pus samples, the results were similar as of urine samples viz, imipenem was most effective with 100% sensitivity followed by amikacin with 14.28% resistance. The results of antibiotic-resistance pattern in E.coli isolates from urine, pus and sputum samples are summarized in [Table 2].
|Table 2: Antibiotic resistance pattern in E. coli isolates from urine, pus and sputum samples|
Click here to view
The MAR index varied considerably the lowest MAR index was 0.18 and the highest MAR index was 0.89 [Table 3]. Overall the maximum population of E. coli isolates (17 in number) belongs to an MAR index of 0.6. The E. coli isolates from urine sample had the maximum population (20 in number) with MAR index above 0.6 when compared to isolates from other samples. It is interesting to note that majority of E. coli isolates belong to the groups with MAR index 0.6 and above.
|Table 3: MAR index, sizes and frequency of plasmids detected in E. coli isolated from different human clinical isolates and correlation with resistance profiles|
Click here to view
Plasmid profile revealed that a total of 10 different-sized plasmids were possessed by the isolates. The smallest plasmid was of size≤2.0 kb and the largest was above 23.13 kb (see [Figure 1]). It was an interesting finding that the maximum number of resistant E. coli isolates belongs to MAR index 0.6 and 0.7 and these groups also possessed maximum variation of plasmid size (see [Table 3]). The number of plasmid bands in low and medium resistance profile (groups with MAR index 0.5 and below) varied between 1-3, while the number of plasmid bands in the high resistance profile (group above 0.5 MAR index) varied between 4-10.Plasmid sized 21 kb was the most common plasmid which was present in six MAR index groups (0.1, 0.2, 0.5, 0.6, 0.7 and 0.9).
|Figure 1: Plasmid profile of test isolates of E. coli (lane 1&8: DNA marker- lambda DNA/hind III digest & 1 kb DNA ladder)|
Click here to view
| Discussion|| |
Epidemiological surveillance of antimicrobial resistance is indispensable for empirical treatment of infections, implementing control measures, and preventing the spread of antimicrobial-resistant microorganisms. 
Pathogenic isolates of E. coli have relatively high potential for developing resistance. High resistance of E. coli to antimicrobial agents tested was observed in this study. This is similar to what was observed previously who reported 100% resistance of their E. coli isolates to ampicillin.  In our study, E. coli isolates showed a high resistance (91.3%) to amoxycillin than what was observed in South Africa, Israel (62%-84%) and Hong Kong, Philippines (64%-82%).  Thus, the result from the present study, showed higher resistance of E. coli isolates to the antibiotic amoxycillin which alarms us of the possibility that the E. coli could have become resistant to many more antibiotics to which it displayed lower resistance. Densenclos et al. reported 53% of their E. coli isolates were resistant to co-trimaxazole and 67% to tetracycline. Subequently, Umolu et al. reported an increase in resistance, showing 69% and 88% to co-trimaxazole and tetracycline respectively which now increased to 78.5% and 91.3%, respectively, in this study.
In recent years, use of fluorquinolones has increased in many countries and emergence of resistance of bacterial isolates to fluoroquinolones has been observed. Consistent step-up in E. coli resistance to ciprofloxacin was observed from 1995 (0.7%) to 2001 (2.5%).  Ciprofloxacin resistance in Portugal was 25.8% and Italy 24.3% while in Germany and the Netherlands it was 15.2% and 6.8%, respectively.  The percentage of ciprofloxacin resistance observed in this study was 89.4%. Similar high resistance of E. coli to Norfloxacin (96.2%) was also observed. The reason for the high resistance to antibiotics may be due to increase in an irrational consumption rate, transmission of resistant isolates between people, self-medication and noncompliance with medication and sales of substandard drug.
Isolates in this study were highly sensitive to nitrofurantoin (76%). Extreme sensitivity of E. coli isolates to nitrofurantoin has earlier been reported.  However, in this study we found that the E. coli isolates were extremely sensitive to imipenem (97.6%) and amikacin (86%). Our results are in contrast to Uma et al. who reported high resistance to imipenem. It is interesting to note that the antibiotics imipenem and amikacin are only available for intravenous administration and provided on prescription only. Hence, the route of administration of these antibiotics may have reduced its misuse which had led to the reduction in the emergence of resistant bacterial strains. In the present study, E. coli isolates from UTI patients were highly sensitive to nitrofurantoin (82.2% sensitive) which correlates to those reported earlier.  However, we found that imipenem was extremely effective in E. coli isolates from UTI patients (100% sensitive), pus samples (100% sensitive) and sputum samples (95.5% sensitive).This was followed by amikacin with sensitivity 85.2% in UTI patients, 85.8% sensitive in pus samples and 95.5% sensitive in sputum samples.
The MAR index data revealed interesting finding that majority of E. coli isolates belong to the group with MAR index above 0.5 (see [Table 3]). This indicates that a very large proportion of the bacterial isolates have been exposed to several antibiotics. Also, the maximum number of resistance E. coli isolates had MAR index between 0.6 and 0.7 and these isolates possessed maximum variation of plasmid size (starting from 2 to 23 kb). Thus, this study shows that the antibiotic resistance in E. coli is controlled by the plasmid number and plasmid size.
| Conclusions|| |
This study showed that antibiotic like Imipenem which display high resistance in other regions across India is still very effective in our environment while conversely an increased resistance to amoxycillin, tetracycline, cotrimoxazole and norfloxacin were observed. In our study, MAR index proved to be helpful in analyzing health risk and the spread of antibiotic resistance. The MAR index data revealed that isolates with lowest and highest MAR index are present in our environment which is a major health risk. Antimicrobial resistance pattern are constantly evolving in our region. There is a necessity for constant antimicrobial sensitivity surveillance and susceptibility testing to be conducted prior to antibiotics prescription. It was also observed that route of antibiotic could contribute in checking disperse of antibiotic resistance. Plamid profile revealed that the antibiotic resistance in this geographical area is plasmid borne. Hence, our data will help clinician in this region provide safe and effective emperic therapies and could contribute to decrease in emergence of resistance.
Moreover, this study shows a good prospect for further research to investigate the exact cause of antibiotic resistance and to understand the mechanism of rapid development of resistance to the newly synthesized antibiotics to which the bacteria were never exposed previously.
| Acknowledgment|| |
The authors are grateful to the SRMS-IMS management for the providing the financial support and technical facillities and to the Department of Microbiology, SRMS-IMS for proving the E. coli samples for this work.
| References|| |
|1.||Karlowsky JA, Jones ME, Draghi DC, Thornsberry C, Sahm DF, Volturo GA. Prevalence of antimicrobial susceptibilities of bacteria isolated from blood cultures of hospitalized patients in the United States in 2002. Ann Clin Microbiol Antimicrob 2004;3:7. |
|2.||Kahlmeter G. ECO.SENS. An international survey of antimicrobioal susceptibility of pathogens from uncomplicated urinary tract infections: the ECO.SENS projects. J Antimicrob Chemother 2003;51:69-76. |
|3.||Biedenbach DJ, Moet GJ, Jones RN. Occurrence and antimicrobial resistance pattern comparisions among bloodstream infection isolates from the SENTRY antimicrobial surveillance program (1997-2002). Diagn Microbiol Infect Dis 2004;50:59-69. |
|4.||Hadfield TL, Monson MH, Wachsmuth IK. An outbreak of antibiotic-resistant Salmonella Enteritidis in Liberia, West Africa. J infect Dis 1985;151:790-5. |
|5.||Bartoloni A, Pallecchi L, Benedetti M, Fernandez C, Vallejos Y, Guzman E, et al. Multidrug-resistant commensal Escherichia coli in children, Peru and Bolivia. Emerg Infect Dis2006;12:907-13. |
|6.||Aibinu I, Adenipekun E, Odugbemi. Emergence of quinolone resistance amongst Escherichia coli strains isolated from clinical infections in some Lagos state hospitals, in Nigeria. Niger J Health Biomed Sc 2004;3:73-78. |
|7.||Summers DK. The biology of plasmids. Cambridge: Mass Blackwell Sciences Ltd; 1996. |
|8.||Brown JC, Shanahan PM, Jesudason MV, Thomson CJ, Amyes SG. Mutation responsible for reduced susceptibility to 4-quinolonesin clinical isolates of multi-resistant Salmonella typhi in India. J Antimicrobial Chemother 1996;37:891-900. |
|9.||Karmaker S,Biswas D,Shaikh NM,Chatterjee SK,Kataria VK,Kumar R. Role of large plasmid of Salmonella typhi encoding multiple drug resistance. J Med Microbiol 1991;34:149-51. |
|10.||Couturier M, Bex F, Bergquist PL, Maas WK. Identification and classification of bacterial plasmids. Microbiol Rev 1988;52:375-95. |
|11.||Tenover FC, Hughes JM. The challenges of emerging infectious diseases. Development and spread of multiply-resistant bacteria pathogens. JAMA 1996;275:300-4. |
|12.||Kolár M, Urbánek K, Látal T. Antibiotic selective pressure and development of bacteria resistance. Int J Antimicrob Agents2001;17:357-63. |
|13.||World Health Organization. Improve and expand surveillance. Antibiotic resistance: synthesis of recommendations by expert policy groups. Switzerland: Geneva; 2001. p. 15-31. |
|14.||Fujita M, Ike M. Waste waters treatment using genetically engineered microorganisms. Basel; Technomic Publishing Company: 1994. |
|15.||Cheesbrough M. District Laboratory Practice in Tropical Countries, Part 2. Cambridge,UK: Cambridge University Press:2000.p. 434. |
|16.||Clinical Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing; fourteenth informational supplement (M100-S14).2004;24. |
|17.||Krumperman PH. Multiple antibiotics resistance indexing of E. coli to identify high risks sources of faecal contamination of foods. App Environ Microbiol1983;46:165-70. |
|18.||Sambrook J, Frish EF, Maniatis T.Molecular cloning. A Laboratory Manual. 2 nd ed. Cold spring Harbor NY: Cold spring Harbor Laboratory press; 1982. |
|19.||Goossens H, Sprenger MJ. Community acquired infections and bacterial resistance.BMJ 1998;317:654-7. |
|20.||Stelling JM, Travers K, Jones RN, Turner PJ, O'Brien TF, Levy SB. Integrating Escherichiacoli antimicrobial susceptibility data from multiple surveillance programs. Emerg Infect Dis 2005;11:873-82. |
|21.||Desenclos JC, Zergabachew A, Desmoulins B, Chouteau L, Desve G, Admassu M. Admassu. Clinical microbiological and antibiotic susceptibility pattern of diarrhea in Korem, Ethopia. J Trop Med Hyg1988;91:296-301. |
|22.||Idia UP, Omigie O, Tatfeng Y, Omorogbe FI, Aisabokhale F, Ugbodagah OP. Antimicrobial susceptibility and plasmid profile of Escherichia coli isolates obtained from different human clinical specimens in Lagos-Nigeria. J Am Sci 2006;2:70-6. |
|23.||Bolon MK, Wright SB, Gold HS, Carmeli Y. The magnitude of the association between fluoroquinolone use and quinolone-resistant Escherichia coli and Klebsiella pneumoniae may be lower than previously reported. Antimicrob Agents Chemother 2004;48:1934-40. |
|24.||Oteo J, Lázaro E, de Abajo FJ, Baquero F, Campos J; Spanish members of EARSS. Antimicrobial-resistant invasive Escherichia coli, Spain. Emerg Infect Dis2005;11:546-53. |
|25.||Bonten M, Stobberiug E, Phillips J, Houben A. High prevalence of antibiotic resistant Escherichia coli in feacal samples of students in Southeast of The Netherlands. J Antimicrob Chemother 1990;26:585-92. |
|26.||Uma B, Prabhakar K, Rajendran S, Kavitha K, Sarayu YL. Antibiotic sensitivity and plasmid profiles of Escherichia coli isolated from pediatric diarrhea. J Glob Infect Dis 2009;1:107-10. |
Ajay Francis Christopher
Central Reseach Laboratory, Department of Biochemistry, SRMS Institute of Medical Sciences, Ram Murti Purum 13.2 Km, Bareilly-Nanital Road, Bareilly-243202, Uttar Pradesh
Source of Support: None, Conflict of Interest: None
[Table 1], [Table 2], [Table 3]